Matthias B Wittwer (Matthias Wittwer)

Publication Activity (10 Years)

Years Active: 2022-2023
Publications (10 Years): 3

Top Topics

Pulmonary Embolism

Inflammatory Response

Vascular Endothelial Growth Factor

Top Venues

Clinical pharmacology and therapeutics

Nature communications

This page only lists publications with an associated author ORCID identifier.

Publications

Ming Jiang, Mirjam C W Huizenga, Jonah L Wirt, Janos Paloczi, Avand Amedi, Richard J B H N van den Berg, Joerg Benz, Ludovic Collin, Hui Deng, Xinyu Di, Wouter F Driever, Bogdan I Florea, Uwe Grether, Antonius P A Janssen, Thomas Hankemeier, Laura H Heitman, Tsang-Wai Lam, Florian Mohr, Anto Pavlovic, Iris Ruf, Helma van den Hurk, Anna F Stevens, Daan van der Vliet, Tom van der Wel, Matthias B Wittwer, Constant A A van Boeckel, Pal Pacher, Andrea G Hohmann, Mario van der Stelt
A monoacylglycerol lipase inhibitor showing therapeutic efficacy in mice without central side effects or dependence. Nature communications 14 (1) (2023)
Maciej J Zamek-Gliszczynski, Vishal Sangha, Hong Shen, Bo Feng, Matthias B Wittwer, Manthena V S Varma, Xiaomin Liang, Yuichi Sugiyama, Lei Zhang, Reina Bendayan, null null
Transporters in Drug Development: International Transporter Consortium Update on Emerging Transporters of Clinical Importance. Clinical pharmacology and therapeutics 112 (3) (2022)
Alicia M Kemble, Benoit Hornsperger, Iris Ruf, Hans Richter, Jörg Benz, Bernd Kuhn, Dominik Heer, Matthias B Wittwer, Britta Engelhardt, Uwe Grether, Ludovic Collin
A potent and selective inhibitor for the modulation of MAGL activity in the neurovasculature. PloS one 17 (9) (2022)